Surgery Partners Finalizes Idaho Divestiture and Updates Guidance

Key Facts

In a move reflecting the ongoing portfolio optimization within the healthcare services sector, Surgery Partners has finalized its latest divestiture. According to reports, the company completed the sale of its ownership interests in Idaho Falls surgical facilities to Intermountain Health. This transaction is part of a previously announced strategy aimed at streamlining the company's portfolio of short-stay surgical facilities.

Following the completion of the sale, the company updated its forward-looking financial guidance to reflect the impact of the transaction. This update is a standard corporate action intended to align investor expectations with the company's new asset structure. The divestiture allows the firm to focus resources on its core surgical network and operational efficiency.

Regarding market performance, SGRY stood at $13.93 (close September 16, 2026), having traded between a day low of $13.6 and a high of $14.24. With no major company-specific catalysts in the upcoming 7-day economic calendar, investors will likely monitor how the updated financial guidance influences the stock's valuation in the near term.